Literature DB >> 11151765

High glucose-induced intercellular adhesion molecule-1 (ICAM-1) expression through an osmotic effect in rat mesangial cells is PKC-NF-kappa B-dependent.

C W Park1, J H Kim, J H Lee, Y S Kim, H J Ahn, Y S Shin, S Y Kim, E J Choi, Y S Chang, B K Bang, J W Lee.   

Abstract

AIMS/HYPOTHESIS: Infiltration of mononuclear cells and glomerular enlargement accompanied by glomerular cell proliferation are very early characteristics of the pathophysiology of diabetes. To clarify the mechanism of early diabetic nephropathy, we measured [3H]-thymidine incorporation and cell numbers to show the influence of a high ambient glucose concentration and the osmotic effect on rat mesangial cell proliferation. We also measured the effect of high glucose on the expression of intercellular adhesion molecule-1 and vascular adhesion molecule-1 by flow cytometry and semiquantitative RT-PCR in mesangial cells and the adhesion of leukocytes to mesangial cells. METHODS/
RESULTS: Cells exposed to high D-glucose (30 mmol/l) caused an increase in [3H]-thymidine incorporation and cell numbers at 24 and 48 h and normalized at 72 h (p < 0.05), whereas these changes were not found in high mannitol (30 mmol/l), IL-1 beta, or TNF alpha-stimulated mesangial cells. Cells exposed to high-glucose (15, 30, or 60 mmol/l) or osmotic agents (L-glucose, raffinose and mannitol) showed that intercellular adhesion molecule-1 expression began to increase after 24 h, reached its maximum at 24 and 48 h and gradually decreased afterwards. The stimulatory effects of high glucose and high mannitol on mRNA expression were observed as early as 6 h and reached its maximum at 12 h. Up-regulation of ICAM-1 protein and mRNA was also found in IL-1-beta and TNF-alpha-stimulated mesangial cells. Neither vascular adhesion molecule-1 protein nor mRNA expression was, however, affected by high glucose and high mannitol. Notably, the protein kinase C inhibitors calphostin C and staurosporine reduced high glucose- or high mannitol-induced intercellular adhesion molecule-1 mRNA expression and high glucose-induced proliferation. Furthermore, the NF-kappa B inhibitor N-tosyl-L-phenylalanine chloromethyl ketone reduced high glucose- or high mannitol-induced intercellular adhesion molecule-1 mRNA expression and high glucose-induced proliferation. Results showed that high glucose (15, 30 mmol/l) or high concentrations of osmotic agents remarkably increased the number of adherent leukocytes to mesangial cells (p < 0.01) compared with control cells (5 mmol/l D-glucose). Functional blocking of intercellular adhesion molecule-1 on mesangial cells with rat intercellular adhesion molecule-1 monoclonal antibody, calphostin C, staurosporine, or N-tosyl-L-phenylalanine chloromethyl ketone significantly inhibited high glucose- or high mannitol-induced increase in leukocyte adhesion (p << 0.05). CONCLUSION/
INTERPRETATION: These results suggest that high glucose can upregulate intercellular adhesion molecule-1 protein and mRNA expression but not vascular adhesion molecule-1 expression in mesangial cells and promote leukocyte adhesion through up-regulation of intercellular adhesion molecule-1 through osmotic effect, possibly depending on the protein kinase C nuclear factor-kappa B (PKC-NF-kappa B) pathway. High glucose itself can also promote mesangial cell proliferation through the PKC-NF-kappa B pathways. We conclude that hyperglycaemia in itself seems to be an important factor in the development of early diabetic nephropathy.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11151765     DOI: 10.1007/s001250051567

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  30 in total

Review 1.  Protein kinase C inhibition and diabetic retinopathy: a shot in the dark at translational research.

Authors:  R Donnelly; I Idris; J V Forrester
Journal:  Br J Ophthalmol       Date:  2004-01       Impact factor: 4.638

2.  Aberrant expression of soluble co-stimulatory molecules and adhesion molecules in type 2 diabetic patients with nephropathy.

Authors:  C K Wong; Amy W Y Ho; Peter C Y Tong; C Y Yeung; Juliana C N Chan; Alice P S Kong; Christopher W K Lam
Journal:  J Clin Immunol       Date:  2007-11-17       Impact factor: 8.317

Review 3.  New molecular insights in diabetic nephropathy.

Authors:  Ionel Alexandru Checheriţă; Gina Manda; Mihai Eugen Hinescu; Ileana Peride; Andrei Niculae; Ştefana Bîlha; Angelica Grămăticu; Luminiţa Voroneanu; Adrian Covic
Journal:  Int Urol Nephrol       Date:  2016-01-12       Impact factor: 2.370

Review 4.  Inflammation in diabetic kidney disease.

Authors:  Patricia M García-García; María A Getino-Melián; Virginia Domínguez-Pimentel; Juan F Navarro-González
Journal:  World J Diabetes       Date:  2014-08-15

Review 5.  Inflammation in diabetic nephropathy: moving toward clinical biomarkers and targets for treatment.

Authors:  Federica Barutta; Graziella Bruno; Serena Grimaldi; Gabriella Gruden
Journal:  Endocrine       Date:  2014-10-02       Impact factor: 3.633

6.  Microglia/macrophages migrate through retinal epithelium barrier by a transcellular route in diabetic retinopathy: role of PKCζ in the Goto Kakizaki rat model.

Authors:  Samy Omri; Francine Behar-Cohen; Yvonne de Kozak; Florian Sennlaub; Lourena Mafra Verissimo; Laurent Jonet; Michèle Savoldelli; Boubaker Omri; Patricia Crisanti
Journal:  Am J Pathol       Date:  2011-06-02       Impact factor: 4.307

7.  TLR3-dependent immune regulatory functions of human mesangial cells.

Authors:  Monika Merkle; Andrea Ribeiro; Simone Köppel; Joachim Pircher; Hanna Mannell; Maximilian Roeder; Markus Wörnle
Journal:  Cell Mol Immunol       Date:  2012-04-02       Impact factor: 11.530

Review 8.  Oxidative stress in diabetic nephropathy: basic and clinical information.

Authors:  H Ha; H B Lee
Journal:  Curr Diab Rep       Date:  2001-12       Impact factor: 4.810

9.  Resveratrol prevents renal lipotoxicity and inhibits mesangial cell glucotoxicity in a manner dependent on the AMPK-SIRT1-PGC1α axis in db/db mice.

Authors:  M Y Kim; J H Lim; H H Youn; Y A Hong; K S Yang; H S Park; S Chung; S H Ko; S H Koh; S J Shin; B S Choi; H W Kim; Y S Kim; J H Lee; Y S Chang; C W Park
Journal:  Diabetologia       Date:  2012-10-23       Impact factor: 10.122

10.  Mice deficient in PKCbeta and apolipoprotein E display decreased atherosclerosis.

Authors:  Evis Harja; Jong Sun Chang; Yan Lu; Michael Leitges; Yu Shan Zou; Ann Marie Schmidt; Shi-Fang Yan
Journal:  FASEB J       Date:  2008-11-26       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.